Sivik Global Healthcare LLC Vertex Pharmaceuticals Inc Transaction History

Sivik Global Healthcare LLC

$236 Million
Q3 2024

A detailed history of Sivik Global Healthcare LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sivik Global Healthcare LLC holds 10,000 shares of VRTX stock, worth $4.65 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares

10,000

Previous 15,000 33.33%

Holding current value

$4.65 Million

Previous $7.03 Million 33.85%

% of portfolio

1.97%

Previous 2.53%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$460.0 - $505.78 $2.3 Million - $2.53 Million	-5,000 Reduced 33.33%	10,000 $4.65 Million
Q2 2024 Jul 29, 2024	BUY	$392.81 - $485.53 $1.57 Million - $1.94 Million	4,000 Added 36.36%	15,000 $7.03 Million
Q1 2024 Apr 30, 2024	SELL	$407.69 - $446.08 $611,535 - $669,120	-1,500 Reduced 12.0%	11,000 $4.6 Million
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $13,720 - $16,427	40 Added 0.32%	12,500 $5.09 Million
Q3 2023 Nov 06, 2023	SELL	$338.18 - $362.46 $520,797 - $558,188	-1,540 Reduced 11.0%	12,460 $4.33 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $314,420 - $351,910	-1,000 Reduced 6.67%	14,000 $4.93 Million
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $4.29 Million - $4.82 Million	15,000 New	15,000 $4.33 Million
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $2.81 Million - $3.32 Million	-15,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $3.11 Million - $3.62 Million	15,000 New	15,000 $3.22 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $7.67 Million - $9.09 Million	-30,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $1.13 Million - $1.48 Million	5,000 Added 20.0%	30,000 $5.63 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1.5 Million - $1.86 Million	-7,500 Reduced 23.08%	25,000 $4.43 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $1.25 Million - $1.68 Million	-7,500 Reduced 18.75%	32,500 $7.12 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $1.66 Million - $1.87 Million	10,000 Added 33.33%	40,000 $6.78 Million
Q1 2019 May 08, 2019	SELL	$163.73 - $194.7 $818,650 - $973,500	-5,000 Reduced 14.29%	30,000 $5.52 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $1.44 Million - $1.66 Million	-8,600 Reduced 19.72%	35,000 $6.75 Million
Q2 2018 Aug 06, 2018	BUY	$145.72 - $169.96 $1.25 Million - $1.46 Million	8,600 Added 24.57%	43,600 $7.41 Million
Q1 2018 May 08, 2018	SELL	$151.6 - $177.13 $1.52 Million - $1.77 Million	-10,000 Reduced 22.22%	35,000 $5.7 Million
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $686,400 - $777,750	-5,000 Reduced 10.0%	45,000 $6.74 Million
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $7.41 Million - $8.11 Million	50,000	50,000 $7.6 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Account

Sivik Global Healthcare LLC Vertex Pharmaceuticals Inc Transaction History